Acadia Healthcare (NASDAQ:ACHC - Get Free Report) has been assigned a $28.00 target price by research analysts at Royal Bank Of Canada in a research note issued to investors on Wednesday, Marketbeat.com reports. The brokerage currently has an "outperform" rating on the stock. Royal Bank Of Canada's price objective indicates a potential upside of 33.46% from the stock's current price.
A number of other research firms have also recently issued reports on ACHC. Guggenheim lowered their price objective on Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating on the stock in a research report on Thursday, August 7th. Mizuho lowered their price target on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 14th. Stephens upgraded Acadia Healthcare to a "hold" rating in a research report on Monday, June 2nd. UBS Group lowered their price target on Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating on the stock in a research report on Thursday, August 7th. Finally, Cowen reiterated a "buy" rating on shares of Acadia Healthcare in a research report on Thursday, August 7th. Five research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat, Acadia Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $40.77.
Read Our Latest Analysis on ACHC
Acadia Healthcare Stock Performance
ACHC opened at $20.98 on Wednesday. The stock has a market cap of $1.94 billion, a PE ratio of 13.89, a P/E/G ratio of 4.08 and a beta of 0.88. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73. Acadia Healthcare has a 1 year low of $17.13 and a 1 year high of $82.40. The stock's 50 day simple moving average is $21.97 and its 200-day simple moving average is $26.94.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.71 by $0.12. The business had revenue of $869.23 million for the quarter, compared to analysts' expectations of $839.59 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%. Acadia Healthcare's quarterly revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.91 earnings per share. Sell-side analysts forecast that Acadia Healthcare will post 3.38 EPS for the current year.
Hedge Funds Weigh In On Acadia Healthcare
Several large investors have recently made changes to their positions in ACHC. Russell Investments Group Ltd. lifted its stake in shares of Acadia Healthcare by 21.4% during the fourth quarter. Russell Investments Group Ltd. now owns 18,421 shares of the company's stock valued at $730,000 after acquiring an additional 3,248 shares during the period. Cerity Partners LLC lifted its stake in shares of Acadia Healthcare by 52.1% during the fourth quarter. Cerity Partners LLC now owns 50,060 shares of the company's stock valued at $1,985,000 after acquiring an additional 17,138 shares during the period. Raymond James Financial Inc. acquired a new position in shares of Acadia Healthcare during the fourth quarter valued at $5,134,000. Capital Fund Management S.A. acquired a new position in shares of Acadia Healthcare during the fourth quarter valued at $547,000. Finally, Treasurer of the State of North Carolina lifted its stake in shares of Acadia Healthcare by 0.6% during the fourth quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company's stock valued at $1,586,000 after acquiring an additional 250 shares during the period.
About Acadia Healthcare
(
Get Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
See Also

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.